Immunology of Diabetes
The research group dedicated to the immunology of diabetes carries out both basic and translational research with the aim of developing preventive immunotherapeutics for type 1 Diabetes and to identify the mechanisms of pathogenicity and regeneration in auto-immune diseases.
Immunotherapies for the prevention and treatment of type 1 diabetes
The line of research aims to stop the autoimmune response using innovative therapies to re-establish the cellular tolerance of the insulin-producing cells.
Biomarkers for the regeneration of autoimmune diseases
The line of research aims to define new regeneration biomarkers in target tissues in autoimmune diseases.
Pathogenic mechanisms of autoimmunity
This line of research aims to identify the inflammatory mechanisms of the specific immune responsible for destruction of insulin-producing beta cells.
Pediatric type 1 diabetes: tolerance, spontaneous remission and biomarkers
The aim of this line is to explore mechanisms of tolerance restablishment in children at the onset of the disease, and to define new biomarkers of remission.
This line of research is funded by DiabetesCERO.
Marta Vives-Pi, PhD, Principal Investigator
(+34) 93 497 86 66